Allan E Rodriguez
Affiliation: University of Miami
- Substituting abacavir for hyperlipidemia-associated protease inhibitors in HAART regimens improves fasting lipid profiles, maintains virologic suppression, and simplifies treatmentPhilip H Keiser
University of Texas Southwestern Medical Center, Dallas, Texas, USA
BMC Infect Dis 5:2. 2005..Hyperlipidemia secondary to protease inhibitors (PI) may abate by switching to anti-HIV medications without lipid effects...
- Differences in HIV-related hospitalization trends between Haitian-born blacks and US-born blacksAllan E Rodriguez
Division of Infectious Diseases, Department of Medicine, University of Miami, Miller School of Medicine, Miami, FL 33136, USA
J Acquir Immune Defic Syndr 45:529-34. 2007..To examine the HIV care needs and hospital admission patterns of HIV-positive Haitian-born blacks (Haitians) and compare them with those of US-born blacks (Blacks)...
- Effect of class-specific therapy interruption on persistence of HIV type 1 antiretroviral resistanceRafael E Campo
Division of Infectious Diseases, University of Miami School of Medicine, 1500 NW 12th Avenue, 8th Floor West, Miami, FL 33136, USA
AIDS Res Hum Retroviruses 19:653-6. 2003..We hypothesize that this finding may be due to nonspecific selective pressure (i.e., to nucleoside reverse transcriptase inhibitors) selecting out PI- and, to a lesser extent, NNRTI-resistant viral variants...
- Depressive symptoms and food insufficiency among HIV-infected crack users in Atlanta and MiamiNicholas S Vogenthaler
Division of Infectious Diseases, Emory University School of Medicine, Atlanta, GA 30303, USA
AIDS Behav 15:1520-6. 2011..Improved recognition and mitigation of these conditions will help alleviate their contribution to HIV-related adverse health outcomes...
- Early virologic nonresponse to tenofovir, abacavir, and lamivudine in HIV-infected antiretroviral-naive subjectsJoel E Gallant
Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA
J Infect Dis 192:1921-30. 2005..Antiretroviral combinations that reduce the number of pills and dosing frequency have the potential to simplify therapy. We compared 2 regimens dosed as 2 pills once daily...
- A randomized controlled trial of Structural Ecosystems Therapy for HIV medication adherence and substance abuse relapse preventionDaniel J Feaster
Center for Family Studies, Department of Epidemiology and Public Health, Leonard M Miller School of Medicine, University of Miami, Miami, FL 33136, USA
Drug Alcohol Depend 111:227-34. 2010..Substance abuse in women with HIV/AIDS overshadows other priorities, including health care. Substance abuse may cause women to avoid health care systems and not adhere to their medication regimen...
- Food insufficiency among HIV-infected crack-cocaine users in Atlanta and MiamiNicholas S Vogenthaler
Division of Infectious Diseases, School of Medicine, Emory University, Atlanta, GA 30303, USA
Public Health Nutr 13:1478-84. 2010..To measure the occurrence and correlates of food insufficiency among HIV-infected crack-cocaine users in Atlanta and Miami, USA...
- HIV medical providers' perceptions of the use of antiretroviral therapy as nonoccupational postexposure prophylaxis in 2 major metropolitan areasAllan E Rodriguez
Division of Infectious Diseases, Department of Medicine, University of Miami Miller School of Medicine, Miami, Florida Department of Epidemiology and Biostatistics, George Washington University, Washington, D C Department of Sociomedical Sciences, Mailman School of Public Health, Columbia University, New York Department of Public Health Sciences, University of Miami Miller School of Medicine, Miami, Florida District of Columbia Department of Health, HIV AIDS, Hepatitis, STD, and TB Administration, Washington, D C and Miami Dade County Health Department, Office of HIV AIDS Services, Miami, Florida
J Acquir Immune Defic Syndr 64:S68-79. 2013....
- Differences in the frequency of resistance to antiretroviral drug classes among human immunodeficiency virus type 1 clinical isolatesRafael E Campo
Division of Infectious Diseases, University of Miami School of Medicine, Miami, Florida, USA
J Clin Microbiol 41:3376-8. 2003....
- Efficacy and Safety of Abacavir/Lamivudine/Zidovudine Plus Tenofovir in HBV/HIV-1 Coinfected Adults: 48-Week DataAllan E Rodriguez
University of Miami, Miami, Florida, USA
Open AIDS J 4:167-70. 2010..These results demonstrate that abacavir/lamivudine/zidovudine and tenofovir were well tolerated with sustained HIV-1 and HBV antiviral activity through 48 weeks in HBV/HIV-coinfected, antiretroviral-naïve subjects...
- Prevalence of antiretroviral drug resistance and resistance-associated mutations in antiretroviral therapy-naïve HIV-infected individuals from 40 United States citiesLisa Ross
GlaxoSmithKline, Research Triangle Park, NC 27709, USA
HIV Clin Trials 8:1-8. 2007..As treatment strategies and utilization of antiretroviral drugs evolve, patterns of transmitted mutations may shift...
- Lopinavir/ritonavir maintenance monotherapy after successful viral suppression with standard highly active antiretroviral therapy in HIV-1-infected patientsRafael E Campo
AIDS 19:447-9. 2005